HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

487.717

+5.3601.11%

Number of Gainers:21

Number of Losers:5

Number of Flat:7

PE:- -

High:489.931

Open:482.072

Low:481.405

Close:482.357

Volume:21.35M

Turnover:527.05M

Market Cap:310.17B

Float Cap:275.52B

Loading ...

Venus Medtech Hangzhou - Subscription Price Per Share is Hk$1.078

THOMSON REUTERS

Venus MedTech Agrees Private Placement of 184,536,703 Shares at HKD 1.08 Each

Alphamab Oncology Files HKEX Next-Day Return Disclosing Share Buyback at HKD 8.28 Each

Market Wrap September 10: Innovation Drug Shares Dip Amid Clinical Setback, Bank Stocks Post Modest Gains

AH Share Premium Rankings: September 10 Market Close Update

Tellgen's Subsidiary Device Registration Application Accepted by Regulator

Northeast Securities: Innovative Drug BD and Commercialization Deliver Consistent Wins, CXO Exceeds Projections, Traditional Segments Approach Turnaround

Ascletis Pharma Surges on US Obesity Drug Trial Launch

Hong Kong Stock Market Highlights: JXR Advances Female Health Translational Medicine Platform

AI-Driven Drug Candidate From INSILICO Reaches Major Milestone As Phase 3 Trial Enrolls First Patients

LIFETECH SCI's LantvalTM Aortic Valve Replacement System Clears NMPA Fast-Track Review for Innovative Devices

Hbm Holdings Says Solstice Oncology Launches Series a Financing Round

Pharmaceutical Firms Divest Assets to Bolster Core Operations

Lee's Pharm Secures Exclusive Rights to Develop and Market Novel PARP1 Inhibitor Across Greater China and Southeast Asia

Trump Unveils Midterm Strategy: Tax Cuts and "MAHA Movement" Take Center Stage, Targeting Pharma and Processed Food Sectors

Everest Medicines Unit Enters Supply, Distribution Cooperation Contract

MT Newswires Live

Henlius CEO Zhu Jun: Systematic Globalization Aims for Long-Term Gains, Innovative Drug Revenue Set to Surpass Biosimilars by 2030

Everest Medicines Forms Strategic Alliance with Hissen for China Market Expansion

Genfleet-B Repurchases 75,000 Shares for HK$1.96 Million on September 9

HBM Holdings' Strategic Partner Secures $225M Series A, Launches Operations

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/BK1574/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":487.71664,"timestamp":1789611959942,"preClose":482.35672,"halted":0,"volume":21347061,"delay":0,"changeRate":0.011112,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":5.359924,"latestTime":"09-17 10:26:00","open":482.07187,"high":489.93134,"low":481.40475,"amount":527054016,"amplitude":0.017677,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1789617600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789608600000,1789617600000],[1789621200000,1789632000000]],"pbRate":3.604829,"peRate":160.310337,"turnoverRate":0.000811,"increases":21,"decrements":5,"flats":6,"marketCap":310174989968,"floatMarketCap":275517247240},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":489.93134,"amplitude":0.017677,"preClose":482.35672,"low":481.40475,"pbRate":"3.604829","latestPrice":487.71664,"volume":21347061,"delay":0,"open":482.07187,"prevYearClose":556.26263,"prevWeekClose":483.155,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":496.758,"twentyDayClose":517.015,"sixtyDayClose":440.071,"secType":"PLATE","market":"HK","turnoverRate":0.000811,"peRate":160.310337,"marketCap":310174989968,"floatMarketCap":275517247240,"timestamp":1789611959942,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":21,"down":5,"flat":7},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666596916","title":"Venus Medtech Hangzhou - Subscription Price Per Share is Hk$1.078","url":"https://stock-news.laohu8.com/highlight/detail?id=2666596916","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666596916?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:12","pubTimestamp":1789045939,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nFWN4520CM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","02500","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666596961","title":"Venus MedTech Agrees Private Placement of 184,536,703 Shares at HKD 1.08 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2666596961","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666596961?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:11","pubTimestamp":1789045904,"startTime":"0","endTime":"0","summary":"Venus MedTech agrees private placement of 184,536,703 shares at HKD 1.08 eachVenus Medtech signed a subscription agreement on Sept. 10, 2026 for 184,536,703 new shares at HKD 1.08.Share sale size: HKD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL1grvnL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1574","02500","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666567647","title":"Alphamab Oncology Files HKEX Next-Day Return Disclosing Share Buyback at HKD 8.28 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2666567647","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666567647?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:42","pubTimestamp":1789036976,"startTime":"0","endTime":"0","summary":"Alphamab Oncology files HKEX next-day return disclosing share buyback at HKD 8.28 eachAlphamab Oncology repurchased 164,000 shares on Sept. 10, holding them as treasury shares; no shares were cancelle","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL4bHKDg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173269814","title":"Market Wrap September 10: Innovation Drug Shares Dip Amid Clinical Setback, Bank Stocks Post Modest Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1173269814","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173269814?lang=en_us&edition=fundamental","pubTime":"2026-09-10 16:55","pubTimestamp":1789030552,"startTime":"0","endTime":"0","summary":"Hong Kong equities extended their losing streak as escalating Middle East tensions and rising oil prices stoked inflation concerns. A combination of factors, including clinical trial risk events,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","LNGR","ABEQ","VMAX","EQRR","159992","MEDX","BK4585","ROPE","BK4588","SPVM","FDN","IBBQ","PRF","DFLV","BKDV","VALQ","VLUE","VUSV","CGVV","SWP","BK1161","BK4550","PY","VTV","TALV","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120089169","title":"AH Share Premium Rankings: September 10 Market Close Update","url":"https://stock-news.laohu8.com/highlight/detail?id=1120089169","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120089169?lang=en_us&edition=fundamental","pubTime":"2026-09-10 16:23","pubTimestamp":1789028611,"startTime":"0","endTime":"0","summary":"As of the market close on September 10, data reveals the latest rankings for A-H share premium ratios, with NE Electric (00042), ZHEJIANG SHIBAO (01057), and HOLLY FUTURES (03678) claiming the top...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1554","HK0000352291.HKD","03130","IE00B29SXG58.USD","LU0862451753.SGD","LU1807302812.USD","LU0345780521.USD","LU0320764755.SGD","BK1148","LU0880133367.SGD","SG9999002463.SGD","LU0531971595.HKD","02218","IE00B3M56506.USD","HK0000320264.USD","LU0417516738.SGD","LU0588546209.SGD","00187","BK1564","03188","LU2394011477.USD","01033","LU1023057109.AUD","BK1574","IE00BVYPNQ40.USD","BK1551","LU0348766576.USD","LU1675838814.USD","LU2778985437.USD","LU0469268626.HKD","LU0049853897.USD","BK1592","02827","LU2177674079.SGD","SG9999004220.SGD","IE00BYV24P56.USD","LU1303224171.USD","BK1198","LU0287142896.SGD","BK1249","06185","BK1506","BK1507","LU1211504680.USD","BK1147","LU0672654166.SGD","83188","BK1170","LU1244550221.USD","BK1514","LU2097828631.EUR","BK1593","IE00BF5LJ272.USD","LU1152091168.USD","SG9999001093.SGD","IE0032431581.USD","LU2039709279.SGD","LU0214875030.USD","LU1224709979.USD","BK1521","LU0052750758.USD","LU2294711473.HKD","LU1770034418.SGD","06826","03200","LU0228659784.USD","BK1515","BK1163","01349","00300","BK1533","LU0082770016.USD","LU0828238088.HKD","LU0061477393.USD","BK1144","HK0000306701.USD","BK1522","159982","LU0327786744.USD","LU1244550494.USD","LU0348816934.USD","LU1481107354.HKD","BK1110","LU0561508036.HKD","02068","LU0082770016.SGD","LU0456854461.SGD","LU0543330566.HKD","BK1141","IE00B031J352.USD","BK1214","LU0163747925.USD","LU2399975544.HKD","LU1242518857.USD","LU1961090484.USD","LU2097828474.EUR","LU1769817096.USD","LU0648948544.HKD","LU0502904849.HKD","IE0008369823.USD","LU0329678170.USD","03750","BK1183","LU0315179316.USD","BK1202","IE00BVYPNP33.GBP","BK1223","LU1880383366.USD","LU0620787316.HKD","BK1191","LU0791590937.USD","LU0359201612.USD","LU0211977185.USD","399300","LU0348825331.USD","IE00BGHQDM52.EUR","LU0828237510.HKD","LU0540923850.HKD","LU1282649067.USD","LU2476274308.USD","LU0501845795.SGD","LU0456846285.SGD","LU1993786604.SGD","LU1046422090.SGD","LU0173614495.USD","LU0165289439.USD","02338","LU0067412154.USD","BK1560","BK1125","LU1504937902.USD","LU0890818403.SGD","LU1366334651.USD","LU0140636845.USD","LU0370786039.SGD","BK1610","LU0359201885.HKD","LU0979878070.USD","82846","IE0008368742.USD","LU0640798160.USD","SG9999011746.SGD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","00317","LU0828237940.HKD","LU1282649810.SGD","LU0488056044.USD","LU0051755006.USD","LU0254981946.USD","LU0531970944.HKD","LU0096374516.USD","LU1831875114.USD","LU0039217434.USD","LU0348788117.USD","LU0737861772.HKD","BK1149","LU0048580855.USD","LU2045819591.USD","LU2226246903.HKD","LU0348805143.USD","01057","LU0516422440.USD","LU0871576103.HKD","LU0348827113.USD","LU1794554557.SGD","BK1583","LU0509642566.USD","00991","LU1064131342.USD","LU0593848301.USD","LU0307460666.USD","BK1576","LU1152091754.HKD","LU0918141705.HKD","LU2097828557.USD","01108","IE00BMCWC346.EUR","LU0329678337.USD","BK1190","HK0000320223.HKD","HK0001040168.HKD","LU0149534421.HKD","LU0516422952.EUR","LU0231483743.USD","LU0868486357.SGD","LU0886674414.USD","06745","LU0634319403.HKD","SG9999014674.SGD","IE00BZ08YT58.USD","LU1048596156.SGD","IE00B031HY20.USD","LU1960683339.HKD","BK1594","83130","LU0266512127.USD","LU0345780281.USD","00895","IE0034224299.USD","LU1282648689.USD","BK1562","LU0269904917.USD","LU0572944931.SGD","LU0128522157.USD","06869","07233","LU0117841782.USD","IE00B543WZ88.USD","SG9999006597.SGD","BK1116","LU0359202008.SGD","SG9999001226.SGD","LU0823426480.USD","03308","LU0164939612.USD","BK1140","00553","BK1544","BK1122","LU0823426308.USD","LU0229945570.USD","LU0210526637.USD","BK1546","EWH","LU0791591158.USD","LU0348735423.USD","LU1282649141.HKD","LU1115378108.SGD","LU0266512473.USD","LU0149721374.USD","HK0001040143.USD","02475","LU0918141887.USD","LU0228367735.SGD","LU1105468828.SGD","LU1688375341.USD","LU0043850808.USD","03328","SG9999002828.SGD","LU0516423174.USD","LU0431992006.USD","LU0106252389.USD","LU0456827905.SGD","BK1161","LU0164880469.USD","02846","LU0463099449.HKD","02359","LU1188198961.HKD","01877","LU1880383440.USD","LU1808992512.USD","IE00B0169L03.USD","LU0543330483.HKD","01812","LU1255011170.USD","LU1251922891.USD","LU0328353924.USD","BK1231","LU0348767384.USD","BK1237","LU1813983027.USD","LU0449509016.USD","06066","LU1720050803.USD","LU0314109678.HKD","LU1244550577.SGD","LU0516423091.SGD","03143","BK1530","LU1366334578.USD","LU0589944569.HKD","BK1523","LU0797268264.HKD","LU1242518931.SGD","LU2125910500.SGD","BK1537","BK1505","LU0106959298.USD","LU0244354667.USD","LU0029875118.USD","LU0417516902.SGD","LU0072913022.USD","IE0031814852.USD","BK1171","LU1328277881.USD","LU0348814723.USD","LU2008162690.USD","LU0164865239.USD","LU0737861699.HKD","LU0181495838.USD","BK1552","03968","LU2476274720.SGD","LU0607220059.USD","03678","HK0000306685.HKD","LU1769817179.HKD","06821","LU0384037296.USD","03986","02865","BK1105","LU0708995583.HKD","LU2097828805.USD","LU2242644610.SGD","02899","LU1655091616.SGD","LU0821914370.USD","LU0516422366.SGD","HK0000352382.USD","LU1719994722.HKD","IE00BZ08YR35.GBP","LU2097828714.EUR","LU3063872942.SGD","LU0320764599.SGD","LU1206782309.USD","LU0326950275.SGD","LU0455707207.USD","LU1988902786.USD","LU2264538146.SGD","LU1008478684.HKD","00042","LU1226287529.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199145560","title":"Tellgen's Subsidiary Device Registration Application Accepted by Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=1199145560","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199145560?lang=en_us&edition=fundamental","pubTime":"2026-09-10 11:54","pubTimestamp":1789012483,"startTime":"0","endTime":"0","summary":"Tellgen Corporation (SZSE: 300642) has announced that its controlling subsidiary, Shanghai Maishi Biotechnology Co., Ltd., recently had its medical device registration application accepted for review...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300642","BK0042","HART","09996","BK1574","PTH","GDOC","RSPH","LGHT","MEDX","159883","AGNG","MDEV","BK0046","BK0239","BK1583","LNGR","IEIH","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192676541","title":"Northeast Securities: Innovative Drug BD and Commercialization Deliver Consistent Wins, CXO Exceeds Projections, Traditional Segments Approach Turnaround","url":"https://stock-news.laohu8.com/highlight/detail?id=1192676541","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192676541?lang=en_us&edition=fundamental","pubTime":"2026-09-10 10:08","pubTimestamp":1789006103,"startTime":"0","endTime":"0","summary":"Investment banking firm Northeast Securities Co.,Ltd. has released a research report indicating that the high prosperity of the overseas innovative drug industry is set to continue, allowing domestic...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","IBBQ","WX","000686","BK1161","BK0028","LNGR","BK0188","MEDX","BK0276","BK1574","BK0183","CXO","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175120307","title":"Ascletis Pharma Surges on US Obesity Drug Trial Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=1175120307","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175120307?lang=en_us&edition=fundamental","pubTime":"2026-09-10 09:50","pubTimestamp":1789005025,"startTime":"0","endTime":"0","summary":"Ascletis Pharma-B (01672) shares jumped nearly 5% in early trading, before paring gains to a modest 0.50% increase, reaching HK$10.11 with turnover of HK$1.82 million. The company announced it has...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1191","BK1161","BK1515","01477","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171834211","title":"Hong Kong Stock Market Highlights: JXR Advances Female Health Translational Medicine Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1171834211","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171834211?lang=en_us&edition=fundamental","pubTime":"2026-09-10 09:04","pubTimestamp":1789002291,"startTime":"0","endTime":"0","summary":"JXR (01951) announced plans to further develop a translational medicine platform primarily focused on female health, marking a strategic move to strengthen its presence in this specialized...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1597","BK1574","02142","BK4585","FHCO","00950","00580","BK1219","BK1191","BK1161","01951","BK1583","KCAI","BK1189","BK4588","VXUS","BK1116","06681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103728541","title":"AI-Driven Drug Candidate From INSILICO Reaches Major Milestone As Phase 3 Trial Enrolls First Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=1103728541","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103728541?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:26","pubTimestamp":1789000007,"startTime":"0","endTime":"0","summary":"INSILICO (03696) has announced that its lead artificial intelligence-powered investigational drug, Rentosertib (also known as ISM001-055/INS018_055), has achieved a significant clinical milestone...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIBU","MVPS","QQQ","TECY","09086","LNGR","MDTX","03086","NJUL","NOCT","QDEC","MEDX","07261","159992","QSWN","TARK","07522","03696","AIQU","NEWZ","IBBJ","PSQ","WPAI","07266","06978","BMED","GPIQ","NJAN","QMAR","QQA","LCLG","GK","BK1574","161631","AIFD","PBOT","KOMP","QQQM","QTOC","BK4593","FWD","NAPR","SQQQ","03455","CPNQ","03034","07568","QID","09834","NBDS","QQQX","OGIG","TQQY","TQQQ","02834","CHAT","PSYK","BK1161","BK1141","CWC","DQJN","QLD","IBBQ","AQGX","AGIX","VUSE","MFIG","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156894230","title":"LIFETECH SCI's LantvalTM Aortic Valve Replacement System Clears NMPA Fast-Track Review for Innovative Devices","url":"https://stock-news.laohu8.com/highlight/detail?id=1156894230","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156894230?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:08","pubTimestamp":1788998900,"startTime":"0","endTime":"0","summary":"LIFETECH SCI (01302) has announced that it received an official written notice from the National Medical Products Administration (NMPA) on September 9, 2026, confirming that the LantvalTM aortic...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","01302","BK1583","PTH","09996","HART","RSPH","BK1600","AGNG","GDOC","159883","LGHT","BK1100","MDEV","IEIH","LNGR","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666753136","title":"Hbm Holdings Says Solstice Oncology Launches Series a Financing Round","url":"https://stock-news.laohu8.com/highlight/detail?id=2666753136","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666753136?lang=en_us&edition=fundamental","pubTime":"2026-09-09 23:20","pubTimestamp":1788967253,"startTime":"0","endTime":"0","summary":"Sept 9 (Reuters) - Hbm Holdings Ltd <2142.HK>::*SOLSTICE ONCOLOGY LAUNCHES $225 MILLION SERIES A FINANCING ROUND*Further company coverage: 2142.HK* ((Reuters.Briefs@thomsonreuters.com;))((Reuters Inve","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nRSD12sC1B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","02142","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169429326","title":"Pharmaceutical Firms Divest Assets to Bolster Core Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=1169429326","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169429326?lang=en_us&edition=fundamental","pubTime":"2026-09-09 23:12","pubTimestamp":1788966731,"startTime":"0","endTime":"0","summary":"A growing number of domestic listed pharmaceutical companies have recently disclosed asset disposal announcements, planning to sell partial or full equity stakes in their controlled subsidiaries....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","FOSL","BK4202","BK1161","02196","BK1574","BK1593","BK1191","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183555429","title":"Lee's Pharm Secures Exclusive Rights to Develop and Market Novel PARP1 Inhibitor Across Greater China and Southeast Asia","url":"https://stock-news.laohu8.com/highlight/detail?id=1183555429","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183555429?lang=en_us&edition=fundamental","pubTime":"2026-09-09 22:40","pubTimestamp":1788964828,"startTime":"0","endTime":"0","summary":"Lee's Pharm (00950) has announced that its wholly-owned subsidiary, Lee's Pharm (Hong Kong) Limited, has entered into an exclusive licensing agreement with US-based biotechnology firm 1cBio, Inc. to...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622","BK1191","BK1587","00950","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145691069","title":"Trump Unveils Midterm Strategy: Tax Cuts and \"MAHA Movement\" Take Center Stage, Targeting Pharma and Processed Food Sectors","url":"https://stock-news.laohu8.com/highlight/detail?id=1145691069","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145691069?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:44","pubTimestamp":1788961466,"startTime":"0","endTime":"0","summary":"President Trump has stepped up his campaign efforts ahead of the November midterm elections, adopting a familiar playbook of self-promotion that he has long relied upon. Despite approval ratings...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","159938","159151","09939","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666535781","title":"Everest Medicines Unit Enters Supply, Distribution Cooperation Contract","url":"https://stock-news.laohu8.com/highlight/detail?id=2666535781","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666535781?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:26","pubTimestamp":1788960412,"startTime":"0","endTime":"0","summary":"Everest Medicines (HKG:1952) unit Everest Medicines (China) entered into a strategic cooperation framework agreement with Hasten Biopharmaceutical.The contract is for the supply, distribution, and rel","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1583","01952","MDCO","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107437767","title":"Henlius CEO Zhu Jun: Systematic Globalization Aims for Long-Term Gains, Innovative Drug Revenue Set to Surpass Biosimilars by 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=1107437767","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107437767?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:11","pubTimestamp":1788959461,"startTime":"0","endTime":"0","summary":"During the 2026 Yabuli Forum Summer Annual Meeting, Henlius (02696.HK) Executive Director and CEO Dr. Zhu Jun outlined the company's \"systematic globalization\" strategy in an in-depth conversation,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2322448791.USD","159992","LU2272731600.USD","IBBQ","IE00B5TLWC47.USD","BK1574","HK0000165453.HKD","LU2322448957.HKD","06978","LU1992135399.USD","LU2473716301.USD","HK0000306701.USD","LU2272731865.HKD","BK4588","HK0000320223.HKD","BK4585","PPH","LU2272731782.SGD","LNGR","HK0000306685.HKD","HK0000320264.USD","IBB","MEDX","XPH","02696","LU1992135472.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113083232","title":"Everest Medicines Forms Strategic Alliance with Hissen for China Market Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1113083232","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113083232?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:18","pubTimestamp":1788956296,"startTime":"0","endTime":"0","summary":"Everest Medicines (01952) has announced the signing of a strategic cooperation framework agreement with Hissen on September 9, 2026, under which both parties have agreed to establish a framework for...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952","BK1574","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179497303","title":"Genfleet-B Repurchases 75,000 Shares for HK$1.96 Million on September 9","url":"https://stock-news.laohu8.com/highlight/detail?id=1179497303","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179497303?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:14","pubTimestamp":1788956052,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) announced that on September 9, 2026, the company spent HK$1.9608 million to repurchase 75,000 shares.The buyback transaction reflects the company's ongoing capital management...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1574","02595","159938","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173908290","title":"HBM Holdings' Strategic Partner Secures $225M Series A, Launches Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=1173908290","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173908290?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:18","pubTimestamp":1788952700,"startTime":"0","endTime":"0","summary":"HBM Holdings (02142) has announced that its partner company Solstice Oncology (Solstice) has successfully completed a $225 million Series A funding round and officially commenced operations. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142","BK1583","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":6,"totalSize":218,"code":"91000000","status":"200"}]}}